iofetamine has been researched along with Alzheimer Disease in 52 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Excerpt | Relevance | Reference |
---|---|---|
" Treatment with memantine prevented the chorea movement and the progression of Huntington's disease." | 8.31 | Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023) |
" Treatment with memantine prevented the chorea movement and the progression of Huntington's disease." | 4.31 | Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023) |
"Perfusion in the patients with Alzheimer's disease was decreased compared with that of the subjects." | 2.67 | SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin. ( Cohen, MB; Fitten, LJ; Graham, LS; Lake, RR; Perryman, KM; Sevrin, R, 1992) |
"Patients with Alzheimer's disease (AD) experience a wide array of cognitive deficits, which typically include the impairment of explicit memory." | 1.43 | Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients. ( Akanabe, H; Chikaishi, T; Hayakawa, M; Hayashi, Y; Inuzuka, T; Islam, S; Itoh, M; Itoh, Y; Kobori, M; Li, S; Mori, T; Muro, T; Nakabayashi, R; Nakagawa, K; Nakagawa, T; Nishida, E; Ohta, K; Ohzawa, K; Saito, K; Suzuki, C; Ueda, M; Wang, MX; Yamada, Y; Yanagida, D, 2016) |
"Twenty-three patients with probable Alzheimer's disease, 22 patients with mild cognitive impairment who eventually developed Alzheimer's disease, eight patients with mild cognitive impairment who did not develop dementia, and 19 cognitively normal subjects were included in the study." | 1.31 | Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. ( Arai, H; Chiba, H; Higuchi, M; Hirai, H; Itoh, M; Maruyama, M; Matsui, T; Okamura, N; Sasaki, H; Seki, T; Tanji, H, 2002) |
"In patients with Alzheimer's disease, the CBF (ratio to cerebellum) decreased significantly in the frontal cortex and the parietal cortex compared with the control values." | 1.29 | [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP]. ( Kitamura, S; Komaba, Y; Komiyama, T; Koshi, Y; Mishina, M; Ohyama, M; Sakayori, O; Terashi, A; Tsuganesawa, T, 1996) |
"123I-IMP-SPECT in a patient with presenile dementia with motor neuron disease differed significantly from uptake in a case with Alzheimer's disease." | 1.28 | [123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease]. ( Mitsuyama, Y, 1989) |
"Eighteen patients with Alzheimer's disease (AD), 5 patients with Pick disease (PD), 6 patients with other types of degenerative dementia (O) and 12 age-matched normal control subjects (N) were studied using N-isopropyl p-[I-123]iodoamphetamine (I-123 IMP) with SPECT." | 1.28 | [N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease]. ( Iio, M; Kosaka, N; Momose, T; Nishikawa, J; Ohtake, T; Watanabe, T; Yoshikawa, K, 1989) |
"Iofetamine I 123 uptake was measured in right and left frontal, temporal, parietal, and occipital cortices." | 1.27 | Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. ( English, R; Growdon, JH; Holman, BL; Johnson, KA; Mueller, SP; Nagel, JS; Rosen, TJ, 1988) |
"One patient with early Alzheimer's disease was classified as normal by two of the four observers." | 1.27 | Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. ( Chang, CC; Cohen, MB; Fitten, J; Graham, LS; Kulkarni, MK; Lake, R; Metter, EJ; Sevrin, R; Woodruff, N; Yamada, L, 1986) |
"In those patients diagnosed as having senile dementia of the Alzheimer type a bilateral reduction in IMP uptake in the temporo-parieto-occipital region was always seen." | 1.27 | Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. ( Besson, J; Cherryman, G; Crawford, J; Gemmell, H; Sharp, P; Smith, F, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (32.69) | 18.7374 |
1990's | 19 (36.54) | 18.2507 |
2000's | 11 (21.15) | 29.6817 |
2010's | 4 (7.69) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Saigoh, K | 1 |
Hirano, M | 1 |
Mitsui, Y | 1 |
Oda, I | 1 |
Ikegawa, A | 1 |
Samukawa, M | 1 |
Yoshikawa, K | 2 |
Yamagishi, Y | 1 |
Kusunoki, S | 1 |
Nagai, Y | 1 |
Nakamagoe, K | 1 |
Fujimiya, S | 1 |
Koganezawa, T | 1 |
Kadono, K | 1 |
Shimizu, K | 1 |
Fujizuka, N | 1 |
Takiguchi, S | 1 |
Ueno, T | 1 |
Monzen, T | 1 |
Tamaoka, A | 1 |
Chiba, Y | 1 |
Iseki, E | 1 |
Fujishiro, H | 1 |
Ota, K | 1 |
Kasanuki, K | 1 |
Suzuki, M | 1 |
Hirayasu, Y | 1 |
Arai, H | 9 |
Sato, K | 2 |
Nakagawa, T | 1 |
Itoh, M | 2 |
Ohta, K | 1 |
Hayashi, Y | 1 |
Hayakawa, M | 1 |
Yamada, Y | 1 |
Akanabe, H | 1 |
Chikaishi, T | 1 |
Nakagawa, K | 1 |
Itoh, Y | 1 |
Muro, T | 1 |
Yanagida, D | 1 |
Nakabayashi, R | 1 |
Mori, T | 2 |
Saito, K | 1 |
Ohzawa, K | 1 |
Suzuki, C | 1 |
Li, S | 1 |
Ueda, M | 1 |
Wang, MX | 1 |
Nishida, E | 1 |
Islam, S | 1 |
Kobori, M | 1 |
Inuzuka, T | 1 |
Ishii, K | 2 |
Kanda, T | 1 |
Uemura, T | 1 |
Miyamoto, N | 1 |
Yoshikawa, T | 1 |
Shimada, K | 1 |
Ohkawa, S | 1 |
Minoshima, S | 1 |
Hanyu, H | 7 |
Kume, K | 1 |
Sato, T | 1 |
Hirao, K | 2 |
Kanetaka, H | 2 |
Sakurai, H | 1 |
Iwamoto, T | 4 |
Ushijima, Y | 2 |
Okuyama, C | 2 |
Mori, S | 1 |
Nakamura, T | 1 |
Kubota, T | 2 |
Nishimura, T | 2 |
Sakai, T | 1 |
Kuzuhara, S | 1 |
Mizumura, S | 1 |
Kumita, S | 1 |
Cho, K | 1 |
Ishihara, M | 1 |
Nakajo, H | 1 |
Toba, M | 1 |
Kumazaki, T | 1 |
Ota, T | 1 |
Shinotoh, H | 1 |
Fukushi, K | 2 |
Nagatsuka, S | 2 |
Namba, H | 2 |
Iyo, M | 2 |
Aotsuka, A | 1 |
Tanaka, N | 1 |
Shiraishi, T | 1 |
Tanada, S | 2 |
Irie, T | 2 |
Kasama, S | 1 |
Tachibana, H | 2 |
Kawabata, K | 2 |
Yoshikawa, H | 1 |
Yamada, K | 1 |
Kizu, O | 1 |
Mito, Y | 1 |
Yoshida, K | 1 |
Yabe, I | 1 |
Makino, K | 1 |
Hirotani, M | 1 |
Tashiro, K | 1 |
Kikuchi, S | 1 |
Sasaki, H | 3 |
Shimizu, S | 1 |
Chikamori, T | 1 |
Usui, Y | 1 |
Yamashina, A | 1 |
Koizumi, K | 1 |
Abe, K | 3 |
Gemmell, HG | 2 |
Sharp, PF | 3 |
Evans, NT | 1 |
Besson, JA | 3 |
Lyall, D | 1 |
Smith, FW | 3 |
Ishino, Y | 1 |
Nakata, H | 1 |
Sugita, M | 1 |
Fukuchi, M | 1 |
Abe, S | 4 |
Takasaki, M | 4 |
Tamagami, H | 1 |
Ikota, N | 1 |
Mori, E | 1 |
Kitagaki, H | 1 |
Sakamoto, S | 1 |
Yamaji, S | 1 |
Imamura, T | 1 |
Ikejiri, Y | 1 |
Kono, M | 1 |
Kitamura, S | 2 |
Koshi, Y | 2 |
Komiyama, T | 2 |
Sakayori, O | 2 |
Komaba, Y | 2 |
Ohyama, M | 2 |
Mishina, M | 2 |
Tsuganesawa, T | 2 |
Terashi, A | 2 |
Ishiwata, A | 1 |
Soya, H | 1 |
Nakazawa, M | 1 |
Kumakura, Y | 2 |
Momose, T | 3 |
Oku, S | 2 |
Ohtake, T | 3 |
Nishikawa, J | 3 |
Sasaki, Y | 1 |
Ohtomo, K | 1 |
Okamura, N | 2 |
Shinkawa, M | 1 |
Matsui, T | 2 |
Nakajo, K | 1 |
Maruyama, M | 2 |
Hu, XS | 1 |
Higuchi, M | 1 |
Tanji, H | 1 |
Seki, T | 1 |
Hirai, H | 1 |
Chiba, H | 1 |
Hitose, K | 1 |
Tanaka, K | 1 |
Kuroda, A | 1 |
Hamamoto, M | 1 |
Miyazaki, T | 1 |
Uchiyama, M | 1 |
Nagashi, M | 1 |
Asano, T | 2 |
Suzuki, T | 4 |
Katsunuma, H | 2 |
Cohen, MB | 2 |
Fitten, LJ | 1 |
Lake, RR | 1 |
Perryman, KM | 1 |
Graham, LS | 2 |
Sevrin, R | 2 |
Amino, S | 2 |
Rae-Grant, AD | 1 |
Barbour, PJ | 1 |
Sirotta, P | 1 |
Gross, P | 1 |
Kuwabara, Y | 2 |
Ichiya, Y | 2 |
Otsuka, M | 2 |
Tahara, T | 2 |
Fukumura, T | 2 |
Gunasekera, R | 2 |
Ichimiya, A | 1 |
Masuda, K | 2 |
Kobayashi, Y | 1 |
Hatano, N | 1 |
Johnson, KA | 3 |
Holman, BL | 4 |
Rosen, TJ | 2 |
Nagel, JS | 2 |
English, RJ | 2 |
Growdon, JH | 2 |
O'Connell, RA | 1 |
Van Heertum, RL | 1 |
Billick, SB | 1 |
Holt, AR | 1 |
Gonzalez, A | 1 |
Notardonato, H | 1 |
Luck, D | 1 |
King, LN | 1 |
Mitsuyama, Y | 1 |
Killen, AR | 1 |
Oster, G | 1 |
Colditz, GA | 1 |
Nishizawa, S | 1 |
Yonekura, Y | 1 |
Fujita, T | 1 |
Mukai, T | 1 |
Saji, H | 1 |
Fukuyama, H | 1 |
Miyoshi, T | 1 |
Harada, K | 1 |
Ishikawa, M | 1 |
Hellman, RS | 1 |
Tikofsky, RS | 1 |
Collier, BD | 1 |
Hoffmann, RG | 1 |
Palmer, DW | 1 |
Glatt, SL | 1 |
Antuono, PG | 1 |
Isitman, AT | 1 |
Papke, RA | 1 |
Jagust, WJ | 2 |
Reed, BR | 2 |
Seab, JP | 1 |
Kramer, JH | 1 |
Budinger, TF | 2 |
Kosaka, N | 1 |
Watanabe, T | 1 |
Iio, M | 1 |
Derouesne, C | 1 |
Rancurel, G | 1 |
Le Poncin Lafitte, M | 1 |
Rapin, JR | 1 |
Lassen, MA | 1 |
Mueller, SP | 1 |
English, R | 1 |
Ebmeier, KP | 2 |
Lake, R | 1 |
Metter, EJ | 1 |
Fitten, J | 1 |
Kulkarni, MK | 1 |
Yamada, L | 1 |
Chang, CC | 1 |
Woodruff, N | 1 |
Mueller, ST | 1 |
Walshe, TM | 1 |
Crawford, JR | 1 |
Palin, AN | 1 |
Gemmel, HG | 1 |
Cherryman, GR | 1 |
Sharp, P | 1 |
Gemmell, H | 1 |
Cherryman, G | 1 |
Besson, J | 1 |
Crawford, J | 1 |
Smith, F | 1 |
Gibson, RE | 1 |
Hill, TC | 1 |
Eckelman, WC | 1 |
Albert, M | 1 |
Reba, RC | 1 |
8 trials available for iofetamine and Alzheimer Disease
Article | Year |
---|---|
Relationship between cognitive function and regional cerebral blood flow in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female; | 2002 |
Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation.
Topics: Aged; Alzheimer Disease; Anatomy, Cross-Sectional; Brain; Brain Mapping; Female; Humans; Image Inter | 2003 |
A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Carbon Radioisoto | 2004 |
Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging.
Topics: Aged; Alzheimer Disease; Brain Diseases; Cerebrovascular Circulation; Cognition Disorders; Humans; I | 2005 |
Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Female; Humans; Imaging, | 2005 |
[Cerebral hemodynamics in patients with dementia].
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia, Vascular; Femal | 1996 |
[Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type].
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Data Interpretation, Sta | 1998 |
SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascul | 1992 |
44 other studies available for iofetamine and Alzheimer Disease
Article | Year |
---|---|
Memantine administration prevented chorea movement in Huntington's disease: a case report.
Topics: Aged; Alzheimer Disease; Chorea; Dyskinesias; Female; Humans; Huntington Disease; Iofetamine; Male; | 2023 |
Vestibular Function Impairment in Alzheimer's Disease.
Topics: Acoustic Stimulation; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; | 2015 |
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fl | 2016 |
Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Animals; Antioxidants; Benzothiazoles | 2016 |
Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.
Topics: Aged; Alzheimer Disease; Automation; Cerebrovascular Circulation; Dementia; Diagnosis, Computer-Assi | 2009 |
Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain Mapping; Cerebral Cortex; Cerebrovascu | 2012 |
[Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Female | 2003 |
Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cerebrovascular Circulation; Femal | 2005 |
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine; | 2006 |
Single photon emission tomography with 123I-isopropylamphetamine in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Alzheimer Disease; Amphetamines; Cerebral Infarction; Cerebral Ventricles; Dementia; Diagnosis | 1984 |
[A case of Down's syndrome with progressive dementia of Alzheimer type].
Topics: Adult; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Down Syndrome; Humans; I | 1993 |
A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia, Vascular; Demye | 1993 |
Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Topics: Acetates; Acetylcholinesterase; Alzheimer Disease; Amphetamines; Animals; Brain; Carbon Radioisotope | 1996 |
The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cognition Disorders; Dementia; Diagnosis, Differential | 1996 |
[Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female; Flumazenil; Human | 1996 |
[A quantitative study of regional cerebral blood flow in patients with dementia of Alzheimer type using single photon emission computed tomography--clinical application of the IMP autoradiographic method (IMP ARG method)].
Topics: Aged; Alzheimer Disease; Amphetamines; Autoradiography; Brain; Cerebrovascular Circulation; Female; | 1996 |
[Analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer type].
Topics: Aged; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Humans; Iodine Radioisot | 1998 |
[Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; | 2000 |
Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Diagnosis, Differential; Female; Gyrus Cinguli; Humans | 2002 |
[Diagnostic imaging of dementia by SPECT].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Estrog | 1992 |
[Cerebral hemodynamic difference between early- and late-onset Alzheimer's disease by circumferential profile analysis with 123I-IMP brain SPECT].
Topics: Aged; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Hemodynamics; Humans; Io | 1992 |
[Diagnostic accuracy of single photon emission CT in Alzheimer-type dementia].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Human | 1992 |
[123I-IMP SPECT study on patients with amnestic syndrome].
Topics: Aged; Alzheimer Disease; Amnesia; Amphetamines; Cerebrovascular Circulation; Female; Humans; Iodine | 1992 |
Alzheimer's disease in Down's syndrome with SPECT.
Topics: Alzheimer Disease; Amphetamines; Brain; Down Syndrome; Humans; Iodine Radioisotopes; Iofetamine; Mal | 1991 |
Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.
Topics: Aged; Alzheimer Disease; Amphetamines; Dementia; Dementia, Multi-Infarct; Female; Humans; Iodine Rad | 1990 |
Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain Diseases; Dementia, Multi-Infarct; Diagnosis, Different | 1990 |
[Asymmetry of cerebral blood flow in patients with senile dementia of Alzheimer type by SPECT using I-123 IMP].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Human | 1990 |
Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radioisotopes; Iofetamine; Male | 1990 |
Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.
Topics: Adult; AIDS Dementia Complex; Alzheimer Disease; Amphetamines; Bipolar Disorder; Brain; Brain Mappin | 1989 |
[123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
Topics: Alzheimer Disease; Amphetamines; Brain; Dementia; Female; Humans; Iodine Radioisotopes; Iofetamine; | 1989 |
An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease.
Topics: Alzheimer Disease; Amphetamines; Cerebrovascular Disorders; Humans; Iodine Radioisotopes; Iofetamine | 1989 |
Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
Topics: Alzheimer Disease; Amphetamines; Brain; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascula | 1989 |
Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radio | 1989 |
Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia; Female; Frontal | 1989 |
[N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Dementia; Female; Humans; Iodine Ra | 1989 |
Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography.
Topics: Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Dementia; Diagnosis, Differential; Hum | 1985 |
Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female; Humans; Iodine Ra | 1988 |
A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Dementia, Multi-Infarct; Humans; Io | 1988 |
Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP.
Topics: Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Dementia; Diagnosis, Differential; Eval | 1986 |
Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female | 1987 |
The diagnosis of dementia with single photon emission computed tomography.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia; Female; Humans; | 1987 |
Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labelled compounds in the diagnosis of dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Dementi | 1987 |
Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia.
Topics: Aged; Alcoholism; Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Cerebrovascular Circu | 1986 |
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
Topics: Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Humans; Iodine Radioisotopes; I | 1985 |